{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:46Z","timestamp":1792783426812,"version":"4.5.0"},"reference-count":271,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Firenze","id":[{"id":"https:\/\/ror.org\/04jr1s763","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40272-026-00769-y","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:01:50Z","timestamp":1789495310000},"page":"505-529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How Organ Manifestations Beyond the Bone May Guide Risk Stratification and Treatment Decisions in Chronic Nonbacterial Osteomyelitis"],"prefix":"10.1007","volume":"28","author":[{"given":"Giulia","family":"Inguscio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1295-6179","authenticated-orcid":false,"given":"Christian M.","family":"Hedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"1","key":"769_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-11-47","volume":"11","author":"CM Hedrich","year":"2013","unstructured":"Hedrich CM, Hofmann SR, Pablik J, Morbach H, Girschick HJ. Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2013;11(1):47.","journal-title":"Pediatr Rheumatol Online J"},{"key":"769_CR2","doi-asserted-by":"crossref","unstructured":"Zhao YF, P J. Chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis in children. Pediatr Clin N Am. 2018;65(4):783\u2013800.","DOI":"10.1016\/j.pcl.2018.04.003"},{"issue":"8","key":"769_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/j.1651-2227.2011.02205.x","volume":"100","author":"AF Jansson","year":"2011","unstructured":"Jansson AF, Grote V, Group ES. Nonbacterial osteitis in children: data of a German incidence surveillance study. Acta Paediatr. 2011;100(8):1150\u20137.","journal-title":"Acta Paediatr"},{"issue":"4","key":"769_CR4","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1093\/rheumatology\/keae447","volume":"64","author":"DT Chia","year":"2025","unstructured":"Chia DT, Toms AP, Sanghrajka A, Ramanan AV, Killeen OG, Ilea C, et al. Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of Ireland. Rheumatology (Oxford). 2025;64(4):2162\u201370.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"769_CR5","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3899\/jrheum.210991","volume":"49","author":"S Aden","year":"2022","unstructured":"Aden S, Wong S, Yang C, Bui T, Higa T, Scheck J, et al. Increasing cases of chronic nonbacterial osteomyelitis in children: a series of 215 cases from a single tertiary referral center. J Rheumatol. 2022;49(8):929\u201334.","journal-title":"J Rheumatol"},{"issue":"12","key":"769_CR6","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00296-016-3572-6","volume":"36","author":"A Schnabel","year":"2016","unstructured":"Schnabel A, Range U, Hahn G, Siepmann T, Berner R, Hedrich CM. Unexpectedly high incidences of chronic non-bacterial as compared to bacterial osteomyelitis in children. Rheumatol Int. 2016;36(12):1737\u201345.","journal-title":"Rheumatol Int"},{"issue":"7","key":"769_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3899\/jrheum.161255","volume":"44","author":"A Schnabel","year":"2017","unstructured":"Schnabel A, Range U, Hahn G, Berner R, Hedrich CM. Treatment response and longterm outcomes in children with chronic nonbacterial osteomyelitis. J Rheumatol. 2017;44(7):1058\u201365.","journal-title":"J Rheumatol"},{"issue":"9","key":"769_CR8","doi-asserted-by":"publisher","first-page":"737.e3","DOI":"10.1016\/j.crad.2019.02.021","volume":"74","author":"S Andronikou","year":"2019","unstructured":"Andronikou S, Mendes da Costa T, Hussien M, Ramanan AV. Radiological diagnosis of chronic recurrent multifocal osteomyelitis using whole-body MRI-based lesion distribution patterns. Clin Radiol. 2019;74(9):737.e3-15.","journal-title":"Clin Radiol"},{"issue":"7","key":"769_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1055\/s-0033-1335283","volume":"185","author":"T von Kalle","year":"2013","unstructured":"von Kalle T, Heim N, Hospach T, Langendorfer M, Winkler P, Stuber T. Typical patterns of bone involvement in whole-body MRI of patients with chronic recurrent multifocal osteomyelitis (CRMO). Rofo. 2013;185(7):655\u201361.","journal-title":"Rofo"},{"issue":"8","key":"769_CR10","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/rheumatology\/key143","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford). 2018;57(8):1504.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"769_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11926-012-0239-5","volume":"14","author":"PJ Ferguson","year":"2012","unstructured":"Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012;14(2):130\u201341.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"769_CR12","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10067-025-07306-1","volume":"44","author":"B \u00d6ks\u00fcz Ayd\u0131n","year":"2025","unstructured":"\u00d6ks\u00fcz Ayd\u0131n B, Ayd\u0131n F, Ta\u015f \u00d6, Bah\u00e7eci O, \u00d6z\u00e7akar ZB. Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center. Clin Rheumatol. 2025;44(2):855\u201362.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"769_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2026.104075","volume":"25","author":"A Schnabel","year":"2026","unstructured":"Schnabel A, Reiser C, Beer M, Br\u00fcck N, F\u00f6rster C, Grote V, et al. Diagnosis, treatment and monitoring of chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO): evidence, practice and consensus-based recommendations from the German pediatric rheumatology society (GKJR). Autoimmun Rev. 2026;25(7):104075.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"769_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/acr.23462","volume":"70","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, et al. Consensus treatment plans for chronic nonbacterial osteomyelitis refractory to nonsteroidal antiinflammatory drugs and\/or with active spinal lesions. Arthritis Care Res. 2018;70(8):1228\u201337.","journal-title":"Arthritis Care Res"},{"issue":"2","key":"769_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2015.09.013","volume":"161","author":"SR Hofmann","year":"2015","unstructured":"Hofmann SR, Kubasch AS, Ioannidis C, R\u00f6sen-Wolff A, Girschick HJ, Morbach H, et al. Altered expression of IL-10 family cytokines in monocytes from CRMO patients result in enhanced IL-1\u03b2 expression and release. Clin Immunol. 2015;161(2):300\u20137.","journal-title":"Clin Immunol"},{"issue":"6","key":"769_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11914-017-0405-9","volume":"15","author":"SR Hofmann","year":"2017","unstructured":"Hofmann SR, Kapplusch F, Girschick HJ, Morbach H, Pablik J, Ferguson PJ, et al. Chronic recurrent multifocal osteomyelitis (CRMO): presentation, pathogenesis, and treatment. Curr Osteoporos Rep. 2017;15(6):542\u201354.","journal-title":"Curr Osteoporos Rep"},{"key":"769_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-12-30","volume":"12","author":"R Scianaro","year":"2014","unstructured":"Scianaro R, Insalaco A, Bracci Laudiero L, De Vito R, Pezzullo M, Teti A, et al. Deregulation of the IL-1\u03b2 axis in chronic recurrent multifocal osteomyelitis. Pediatr Rheumatol Online J. 2014;12:30.","journal-title":"Pediatr Rheumatol Online J"},{"key":"769_CR18","doi-asserted-by":"crossref","unstructured":"Brandt D, Sohr E, Pablik J, Schnabel A, Kapplusch F, M\u00e4bert K, et al. CD14. Clin Immunol. 2018;196:77\u201384.","DOI":"10.1016\/j.clim.2018.04.011"},{"key":"769_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2024.103183","volume":"144","author":"A Charras","year":"2024","unstructured":"Charras A, Hofmann SR, Cox A, Schulze F, Russ S, Northey S, et al. P2RX7 gene variants associate with altered inflammasome assembly and reduced pyroptosis in chronic nonbacterial osteomyelitis (CNO). J Autoimmun. 2024;144:103183.","journal-title":"J Autoimmun"},{"issue":"2","key":"769_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/ar2992","volume":"12","author":"C Beck","year":"2010","unstructured":"Beck C, Morbach H, Beer M, Stenzel M, Tappe D, Gattenl\u00f6hner S, et al. Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment. Arthritis Res Ther. 2010;12(2):R74.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"769_CR21","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/jbmr\/zjae141","volume":"39","author":"E Roberts","year":"2024","unstructured":"Roberts E, Charras A, Hahn G, Hedrich CM. An improved understanding of pediatric chronic nonbacterial osteomyelitis pathophysiology informs current and future treatment. J Bone Miner Res. 2024;39(11):1523\u201338.","journal-title":"J Bone Miner Res"},{"issue":"7","key":"769_CR22","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/rheumatology\/keq074","volume":"49","author":"M Colina","year":"2010","unstructured":"Colina M, Pizzirani C, Khodeir M, Falzoni S, Bruschi M, Trotta F, et al. Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology (Oxford). 2010;49(7):1416\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"769_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2016.03.002","volume":"165","author":"CM Hedrich","year":"2016","unstructured":"Hedrich CM. Shaping the spectrum: from autoinflammation to autoimmunity. Clin Immunol. 2016;165:21\u20138.","journal-title":"Clin Immunol"},{"key":"769_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.662047","volume":"8","author":"AL Carvalho","year":"2021","unstructured":"Carvalho AL, Hedrich CM. The molecular pathophysiology of psoriatic arthritis-: the complex interplay between genetic predisposition, epigenetics factors, and the microbiome. Front Mol Biosci. 2021;8:662047.","journal-title":"Front Mol Biosci"},{"key":"769_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100095","volume":"4","author":"DY Zhao","year":"2021","unstructured":"Zhao DY, McCann L, Hahn G, Hedrich CM. Chronic nonbacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO). J Transl Autoimmun. 2021;4:100095.","journal-title":"J Transl Autoimmun."},{"key":"769_CR26","doi-asserted-by":"crossref","unstructured":"Hedrich CM, Roberts E, Inguscio G, Ramanan AV. Addressing the urgent need for clinical trials in chronic nonbacterial osteomyelitis. Lancet Rheumatol. 2026 (in press).","DOI":"10.1016\/S2665-9913(26)00156-6"},{"issue":"Suppl. 2","key":"769_CR27","first-page":"77","volume":"51","author":"KC Duffin","year":"2023","unstructured":"Duffin KC, Thio HB, Helliwell PS. Synovitis, acne, pustulosis, hyperostosis, osteitis, palmoplantar pustulosis, and neutrophilic dermatoses: a GRAPPA 2023 Annual Meeting update. J Rheumatol. 2023;51(Suppl. 2):77\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"769_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1169-3","volume":"14","author":"Y Sun","year":"2019","unstructured":"Sun Y, Li C, Zhu M, Zhang S, Cao Y, Yang Q, et al. Enhanced migration and adhesion of peripheral blood neutrophils from SAPHO patients revealed by RNA-Seq. Orphanet J Rare Dis. 2019;14(1):192.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"769_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/000992288902800201","volume":"28","author":"RS Van Howe","year":"1989","unstructured":"Van Howe RS, Starshak RJ, Chusid MJ. Chronic, recurrent multifocal osteomyelitis: case report and review of the literature. Clin Pediatr (Phila). 1989;28(2):54\u20139.","journal-title":"Clin Pediatr (Phila)"},{"issue":"2","key":"769_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1136\/ard.2004.023838","volume":"64","author":"HJ Girschick","year":"2005","unstructured":"Girschick HJ, Raab P, Surbaum S, Trusen A, Kirschner S, Schneider P, et al. Chronic non-bacterial osteomyelitis in children. Ann Rheum Dis. 2005;64(2):279\u201385.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"769_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1525-1470.2009.00984.x","volume":"26","author":"BE Tlougan","year":"2009","unstructured":"Tlougan BE, Podjasek JO, O\u2019Haver J, Cordova KB, Nguyen XH, Tee R, et al. Chronic recurrent multifocal osteomyelitis (CRMO) and synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with associated neutrophilic dermatoses: a report of seven cases and review of the literature. Pediatr Dermatol. 2009;26(5):497\u2013505.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"769_CR32","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2015.12.003","volume":"43","author":"DD Patel","year":"2015","unstructured":"Patel DD, Kuchroo VK. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity. 2015;43(6):1040\u201351.","journal-title":"Immunity"},{"issue":"1","key":"769_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/1529-0131(200001)43:1<109::AID-ANR14>3.0.CO;2-3","volume":"43","author":"O Vittecoq","year":"2000","unstructured":"Vittecoq O, Said LA, Michot C, Mejjad O, Thomine JM, Mitrofanoff P, et al. Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long term. Arthritis Rheum. 2000;43(1):109\u201319.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"769_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.semarthrit.2012.05.006","volume":"42","author":"MT Nguyen","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum. 2012;42(3):254\u201365.","journal-title":"Semin Arthritis Rheum"},{"key":"769_CR35","first-page":"459","volume":"59","author":"A Goenka","year":"2020","unstructured":"Goenka A, Roderick M, Finn A, Ramanan AV. The jigsaw puzzle of chronic non-bacterial osteomyelitis: are anti-IL17 therapies the next piece? Rheumatology (Oxford). 2020;59:459\u201361.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"769_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jbspin.2017.05.016","volume":"84","author":"D Wendling","year":"2017","unstructured":"Wendling D, Aubin F, Verhoeven F, Prati C. IL-23\/Th17 targeted therapies in SAPHO syndrome: a case series. Jt Bone Spine. 2017;84(6):733\u20135.","journal-title":"Jt Bone Spine"},{"issue":"9","key":"769_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361(9):888\u201398.","journal-title":"N Engl J Med"},{"issue":"2","key":"769_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1173","volume":"12","author":"YCG Liu","year":"2024","unstructured":"Liu YCG, Yeng-Tung TA. Distinct cross talk of IL-17 & TGF-\u03b2 with the immature CD11c+TRAF6(-\/-)-null myeloid dendritic cell-derived osteoclast precursor (mDDOCp) may engage signaling toward an alternative pathway of osteoclastogenesis for arthritic bone loss in vivo. Immun Inflamm Dis. 2024;12(2):e1173.","journal-title":"Immun Inflamm Dis."},{"issue":"1","key":"769_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12016-026-09139-5","volume":"69","author":"Y Zhao","year":"2026","unstructured":"Zhao Y, Tang Y, Zhu X, Hou Y, Li H, Ciccia F, et al. The roles of interleukin-18 in inflammation and autoimmune disease. Clin Rev Allergy Immunol. 2026;69(1):17.","journal-title":"Clin Rev Allergy Immunol"},{"key":"769_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","volume":"13","author":"SA Ihim","year":"2022","unstructured":"Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment. Front Immunol. 2022;13:919973.","journal-title":"Front Immunol"},{"issue":"11","key":"769_CR41","first-page":"1992","volume":"43","author":"C Matucci-Cerinic","year":"2025","unstructured":"Matucci-Cerinic C, Bayindir Y, Longo C, Mori F, Alessi F, Vergani M, et al. Data from a multicentric international study unveils a neglected association between chronic non-bacterial osteomyelitis and inflammatory bowel diseases. Clin Exp Rheumatol. 2025;43(11):1992\u20132000.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"769_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MPG.0000000000003225","volume":"73","author":"MJ Dushnicky","year":"2021","unstructured":"Dushnicky MJ, Beattie KA, Cellucci T, Heale L, Zachos M, Sherlock M, et al. Pediatric patients with a dual diagnosis of inflammatory bowel disease and chronic recurrent multifocal osteomyelitis. J Pediatr Gastroenterol Nutr. 2021;73(5):626\u20139.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"769_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jpn3.70243","volume":"82","author":"M Matar","year":"2026","unstructured":"Matar M, Cebecauerova D, Kolho K-L, Scarallo L, Hussey S, Yerushalmy-Feler A, et al. Chronic nonbacterial osteomyelitis associated with pediatric inflammatory bowel disease: a multicenter retrospective study from the Paediatric inflammatory bowel disease Porto Group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2026;82(2):487\u201394.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"769_CR44","volume":"10","author":"S Costi","year":"2023","unstructured":"Costi S, Germinario S, Pandolfi M, Pellico MR, Amati A, Gattinara M, et al. Chronic nonbacterial osteomyelitis and inflammatory bowel disease: a literature review-based cohort. Children (Basel). 2023;10(3):502.","journal-title":"Children (Basel)"},{"issue":"9","key":"769_CR45","first-page":"1567","volume":"20","author":"H Mielants","year":"1993","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, Maertens M, et al. Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondyloarthropathy: a prospective study. J Rheumatol. 1993;20(9):1567\u201372.","journal-title":"J Rheumatol"},{"key":"769_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.667305","volume":"8","author":"I Pagnini","year":"2021","unstructured":"Pagnini I, Scavone M, Maccora I, Mastrolia MV, Marrani E, Bertini F, et al. The development of extra-articular manifestations in children with enthesitis-related arthritis: natural course or different disease entity? Front Med (Lausanne). 2021;8:667305.","journal-title":"Front Med (Lausanne)."},{"issue":"12","key":"769_CR47","first-page":"2279","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol. 1995;22(12):2279\u201384.","journal-title":"J Rheumatol"},{"issue":"3","key":"769_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gut.45.3.362","volume":"45","author":"JA Tibble","year":"1999","unstructured":"Tibble JA, Sigthorsson G, Foster R, Scott D, Fagerhol MK, Roseth A, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut. 1999;45(3):362\u20136.","journal-title":"Gut"},{"issue":"25","key":"769_CR49","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.3748\/wjg.v19.i25.3931","volume":"19","author":"GJ Marlow","year":"2013","unstructured":"Marlow GJ, van Gent D, Ferguson LR. Why interleukin-10 supplementation does not work in Crohn\u2019s disease patients. World J Gastroenterol. 2013;19(25):3931\u201341.","journal-title":"World J Gastroenterol"},{"issue":"21","key":"769_CR50","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa0907206","volume":"361","author":"E-O Glocker","year":"2009","unstructured":"Glocker E-O, Kotlarz D, Boztug K, Gertz EM, Sch\u00e4ffer AA, Noyan F, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361(21):2033\u201345.","journal-title":"N Engl J Med"},{"issue":"6","key":"769_CR51","doi-asserted-by":"publisher","first-page":"E370","DOI":"10.25011\/cim.v34i6.15898","volume":"34","author":"C Lv","year":"2011","unstructured":"Lv C, Wang Y, Wang J, Zhang H, Xu H, Zhang D. Association of interleukin-10 gene polymorphisms with ankylosing spondylitis. Clin Invest Med. 2011;34(6):E370.","journal-title":"Clin Invest Med"},{"issue":"2","key":"769_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.gastro.2012.04.045","volume":"143","author":"D Kotlarz","year":"2012","unstructured":"Kotlarz D, Beier R, Murugan D, Diestelhorst J, Jensen O, Boztug K, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143(2):347\u201355.","journal-title":"Gastroenterology"},{"issue":"1","key":"769_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","volume":"24","author":"DM Turner","year":"1997","unstructured":"Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1\u20138.","journal-title":"Eur J Immunogenet"},{"key":"769_CR54","doi-asserted-by":"crossref","unstructured":"Schilling FW, A D, M\u00e4rker-Hermann E. Chronic recurrent multifocal osteomyelitis in association with chronic inflammatory bowel disease: entheropathic CRMO. Z Rheumatol. 2003;62(6):527\u201338.","DOI":"10.1007\/s00393-003-0526-7"},{"issue":"4","key":"769_CR55","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00281-015-0488-2","volume":"37","author":"PJ Ferguson","year":"2015","unstructured":"Ferguson PJ, Laxer RM, Ferguson PJ, Laxer RM. New discoveries in CRMO: IL-1\u03b2, the neutrophil, and the microbiome implicated in disease pathogenesis in Pstpip2-deficient mice. Semin Immunopathol. 2015;37(4):407\u201312.","journal-title":"Semin Immunopathol"},{"issue":"2","key":"769_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00393-021-01035-x","volume":"82","author":"MJS Zeus","year":"2023","unstructured":"Zeus MJS, Laws HJ, Fischer U, Borkhardt A, Oommen PT. Results from a pilot study on the oral microbiome in children and adolescents with chronic nonbacterial osteomyelitis. Z Rheumatol. 2023;82(2):123\u201333.","journal-title":"Z Rheumatol"},{"issue":"10","key":"769_CR57","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrrheum.2011.121","volume":"7","author":"JU Scher","year":"2011","unstructured":"Scher JU, Abramson SB. The microbiome and rheumatoid arthritis. Nat Rev Rheumatol. 2011;7(10):569\u201378.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"769_CR58","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.38967","volume":"67","author":"M-E Costello","year":"2015","unstructured":"Costello M-E, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, et al. Brief report: intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 2015;67(3):686\u201391.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"769_CR59","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s003930070059","volume":"59","author":"FW Schilling","year":"2000","unstructured":"Schilling FW, Wagner AD. Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report. Z Rheumatol. 2000;59(5):352\u20133.","journal-title":"Z Rheumatol"},{"issue":"3","key":"769_CR60","first-page":"457","volume":"25","author":"M Colina","year":"2007","unstructured":"Colina M, Lo Monaco A, Khodeir M, Trotta F. Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol. 2007;25(3):457\u201360.","journal-title":"Clin Exp Rheumatol"},{"issue":"1-2","key":"769_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/BF02010639","volume":"20","author":"DW Manson","year":"1989","unstructured":"Manson DW, Wilmot DM, King S, Laxer RM. Physeal involvement in chronic recurrent multifocal osteomyelitis. Pediatr Radiol. 1989;20(1\u20132):76\u20139.","journal-title":"Pediatr Radiol"},{"issue":"5","key":"769_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/ar2812","volume":"11","author":"G Assmann","year":"2009","unstructured":"Assmann G, Kueck O, Kirchhoff T, Rosenthal H, Voswinkel J, Pfreundschuh M, et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther. 2009;11(5):R140.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"769_CR63","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/jid.2014.290","volume":"135","author":"M Kistowska","year":"2015","unstructured":"Kistowska M, Meier B, Proust T, Feldmeyer L, Cozzio A, Kuendig T, et al. Propionibacterium acnes promotes Th17 and Th17\/Th1 responses in acne patients. J Invest Dermatol. 2015;135(1):110\u20138.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"769_CR64","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00431-018-3263-2","volume":"178","author":"PC Zimmermann","year":"2019","unstructured":"Zimmermann PC, Curtis N. The role of Cutibacterium acnes in auto-inflammatory bone disorders. Eur J Pediatr. 2019;178(1):89\u201395.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"769_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2026.104005","volume":"25","author":"S Turner","year":"2026","unstructured":"Turner S, Roberts E, Hall N, Hedrich CM. Treatment of pediatric chronic nonbacterial osteomyelitis: a systematic review. Autoimmun Rev. 2026;25(3):104005.","journal-title":"Autoimmun Rev"},{"key":"769_CR66","unstructured":"OCEBM Levels of Evidence Working Group. The Oxford 2009 levels of evidence. Oxford: Oxford Centre for Evidence-Based Medicine; 2009. https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed 16 Aug 2026."},{"issue":"11","key":"769_CR67","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.3899\/jrheum.160256","volume":"43","author":"SR Hofmann","year":"2016","unstructured":"Hofmann SR, Schnabel A, R\u00f6sen-Wolff A, Morbach H, Girschick HJ, Hedrich CM. Chronic nonbacterial osteomyelitis: pathophysiological concepts and current treatment strategies. J Rheumatol. 2016;43(11):1956\u201364.","journal-title":"J Rheumatol"},{"issue":"5","key":"769_CR68","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/BPO.0b013e318070cbd3","volume":"27","author":"JC Abril","year":"2007","unstructured":"Abril JC, Ramirez A. Successful treatment of chronic recurrent multifocal osteomyelitis with indomethacin: a preliminary report of five cases. J Pediatr Orthop. 2007;27(5):587\u201391.","journal-title":"J Pediatr Orthop"},{"issue":"6","key":"769_CR69","doi-asserted-by":"publisher","first-page":"611","DOI":"10.5144\/0256-4947.2012.611","volume":"32","author":"M Al Hajry","year":"2012","unstructured":"Al Hajry M, Al Jumaah S, Almayouf SM. Chronic recurrent multifocal osteomyelitis: a first report from Saudi Arabia. Ann Saudi Med. 2012;32(6):611\u20134.","journal-title":"Ann Saudi Med"},{"issue":"1","key":"769_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5144\/0256-4947.2012.43","volume":"32","author":"A Alenazi","year":"2012","unstructured":"Alenazi A, Al Sonbul A, Al Jumaah S, Al Mehaidib A, Al-Mayouf SM. A retrospective review of autoinflammatory diseases in Saudi children at a rheumatology clinic. Ann Saudi Med. 2012;32(1):43\u20138.","journal-title":"Ann Saudi Med"},{"issue":"1","key":"769_CR71","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12969-022-00746-y","volume":"20","author":"CM Andreasen","year":"2022","unstructured":"Andreasen CM, Klicman RF, Herlin T, Hauge EM, Jurik AG. Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. Pediatr Rheumatol Online J. 2022;20(1):85.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"769_CR72","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12969-017-0183-z","volume":"15","author":"Y Ata","year":"2017","unstructured":"Ata Y, Inaba Y, Choe H, Kobayashi N, Machida J, Nakamura N, et al. Bone metabolism and inflammatory characteristics in 14 cases of chronic nonbacterial osteomyelitis. Pediatr Rheumatol Online J. 2017;15(1):56.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"769_CR73","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12969-018-0290-5","volume":"16","author":"CS Bhat","year":"2018","unstructured":"Bhat CS, Anderson C, Harbinson A, McCann LJ, Roderick M, Finn A, et al. Chronic non bacterial osteitis- a multicentre study. Pediatr Rheumatol Online J. 2018;16(1):74.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"769_CR74","doi-asserted-by":"publisher","first-page":"e1190","DOI":"10.1542\/peds.2011-3788","volume":"130","author":"A Borzutzky","year":"2012","unstructured":"Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, et al. Pediatric chronic nonbacterial osteomyelitis. Pediatrics. 2012;130(5):e1190\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"769_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00620-3","volume":"19","author":"M Capponi","year":"2021","unstructured":"Capponi M, Pires Marafon D, Rivosecchi F, Zhao Y, Pardeo M, Messia V, et al. Assessment of disease activity using a whole-body MRI derived radiological activity index in chronic nonbacterial osteomyelitis. Pediatr Rheumatol Online J. 2021;19(1):123.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"9","key":"769_CR76","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/ken249","volume":"47","author":"C Catalano-Pons","year":"2008","unstructured":"Catalano-Pons C, Comte A, Wipff J, Quartier P, Faye A, Gendrel D, et al. Clinical outcome in children with chronic recurrent multifocal osteomyelitis. Rheumatology (Oxford). 2008;47(9):1397\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"769_CR77","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1080\/15513815.2021.1978602","volume":"41","author":"E Chang","year":"2022","unstructured":"Chang E, Vickery J, Zaiat N, Sallam E, Hanan A, Baker S, et al. Chronic recurrent multifocal osteomyelitis (CRMO): a study of 12 cases from one institution and literature review. Fetal Pediatr Pathol. 2022;41(5):759\u201370.","journal-title":"Fetal Pediatr Pathol"},{"issue":"8","key":"769_CR78","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1097\/RHU.0000000000001431","volume":"27","author":"S \u00c7i\u00e7ek","year":"2021","unstructured":"\u00c7i\u00e7ek S, \u015eahin N, Karaman ZF, Ta\u015fk\u0131n SN, K\u0131saarslan AP, G\u00fcnd\u00fcz Z, et al. The possible relationship between familial Mediterranean fever and chronic nonbacterial osteomyelitis: coincidence or coexistence? J Clin Rheumatol. 2021;27(8):e342\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"769_CR79","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00296-019-04400-x","volume":"40","author":"S Concha","year":"2020","unstructured":"Concha S, Hern\u00e1ndez-Ojeda A, Contreras O, Mendez C, Talesnik E, Borzutzky A. Chronic nonbacterial osteomyelitis in children: a multicenter case series. Rheumatol Int. 2020;40(1):115\u201320.","journal-title":"Rheumatol Int"},{"issue":"1","key":"769_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/ped.15351","volume":"64","author":"Z Ekici Tekin","year":"2022","unstructured":"Ekici Tekin Z, G\u00fcllero\u011flu NB, \u00c7elikel E, Ayd\u0131n F, Kurt T, Tekg\u00f6z N, et al. Chronic non-bacterial osteomyelitis in children: outcomes, quality of life. Pediatr Int. 2022;64(1):e15351.","journal-title":"Pediatr Int"},{"issue":"1","key":"769_CR81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12969-019-0384-8","volume":"18","author":"A Gaal","year":"2020","unstructured":"Gaal A, Basiaga ML, Zhao Y, Egbert M. Pediatric chronic nonbacterial osteomyelitis of the mandible: Seattle Children\u2019s Hospital 22-patient experience. Pediatr Rheumatol Online J. 2020;18(1):4.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"769_CR82","first-page":"1255","volume":"38","author":"L Gamalero","year":"2020","unstructured":"Gamalero L, Belot A, Zajc Avramovic M, Giani T, Filocamo G, Guleria S, et al. Chronic non-bacterial osteomyelitis: a retrospective international study on clinical manifestations and response to treatment. Clin Exp Rheumatol. 2020;38(6):1255\u201362.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"769_CR83","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/rheumatology\/kel190","volume":"46","author":"A Jansson","year":"2007","unstructured":"Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, et al. Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford). 2007;46(1):154\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"769_CR84","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3109\/03009742.2015.1055514","volume":"44","author":"A Johnsson","year":"2015","unstructured":"Johnsson A, Flat\u00f8 B, Knudsen PK, Lilleby V. Clinical outcome in a Norwegian cohort of patients with chronic recurrent multifocal osteomyelitis. Scand J Rheumatol. 2015;44(6):513\u20134.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"769_CR85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12969-022-00698-3","volume":"20","author":"S Kaut","year":"2022","unstructured":"Kaut S, Van den Wyngaert I, Christiaens D, Wouters C, Noppe N, Herregods N, et al. Chronic nonbacterial osteomyelitis in children: a multicentre Belgian cohort of 30 children. Pediatr Rheumatol Online J. 2022;20(1):41.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"769_CR86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-019-04479-2","volume":"40","author":"MM Kostik","year":"2020","unstructured":"Kostik MM, Kopchak OL, Maletin AS, Mushkin AY. The peculiarities and treatment outcomes of the spinal form of chronic non-bacterial osteomyelitis in children: a retrospective cohort study. Rheumatol Int. 2020;40(1):97\u2013105.","journal-title":"Rheumatol Int"},{"issue":"9","key":"769_CR87","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1111\/1756-185X.12940","volume":"20","author":"T Moussa","year":"2017","unstructured":"Moussa T, Bhat V, Kini V, Fathalla BM. Clinical and genetic association, radiological findings and response to biological therapy in seven children from Qatar with non-bacterial osteomyelitis. Int J Rheum Dis. 2017;20(9):1286\u201396.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"769_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12969-021-00530-4","volume":"19","author":"D O'Leary","year":"2021","unstructured":"O\u2019Leary D, Wilson AG, MacDermott EJ, Lowry C, Killeen OG. Variability in phenotype and response to treatment in chronic nonbacterial osteomyelitis; the Irish experience of a national cohort. Pediatr Rheumatol Online J. 2021;19(1):45.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"769_CR89","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1111\/apa.13420","volume":"105","author":"S Pastore","year":"2016","unstructured":"Pastore S, Ferrara G, Monasta L, Meini A, Cattalini M, Martino S, et al. Chronic nonbacterial osteomyelitis may be associated with renal disease and bisphosphonates are a good option for the majority of patients. Acta Paediatr. 2016;105(7):e328\u201333.","journal-title":"Acta Paediatr"},{"issue":"1","key":"769_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02658-w","volume":"23","author":"C Reiser","year":"2009","unstructured":"Reiser C, Klotsche J, Hospach A, Berendes R, Schnabel A, Jansson AF, et al. First-year follow-up of children with chronic nonbacterial osteomyelitis-an analysis of the German National Pediatric Rheumatologic Database from 2009 to 2018. Arthritis Res Ther. 2009;23(1):281.","journal-title":"Arthritis Res Ther"},{"issue":"Si2","key":"769_CR91","doi-asserted-by":"publisher","first-page":"Si233","DOI":"10.1093\/rheumatology\/kead473","volume":"63","author":"M Robert","year":"2024","unstructured":"Robert M, Giolito A, Reumaux H, Rossi-Semerano L, Guillemin C, Biarrotte L, et al. Extra-osseous manifestations in chronic recurrent multifocal osteomyelitis: a retrospective study. Rheumatology (Oxford). 2024;63(Si2):Si233\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"769_CR92","doi-asserted-by":"publisher","first-page":"386","DOI":"10.24953\/turkjped.2019.03.010","volume":"61","author":"E Sa\u011f","year":"2019","unstructured":"Sa\u011f E, S\u00f6nmez HE, Demir S, Bilginer Y, Ergen FB, Ayd\u0131ng\u00f6z \u00dc, et al. Chronic recurrent multifocal osteomyelitis in children: a single center experience over five years. Turk J Pediatr. 2019;61(3):386\u201391.","journal-title":"Turk J Pediatr"},{"issue":"1","key":"769_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0353-2","volume":"17","author":"A Skrabl-Baumgartner","year":"2019","unstructured":"Skrabl-Baumgartner A, Singer P, Greimel T, Gorkiewicz G, Hermann J. Chronic non-bacterial osteomyelitis: a comparative study between children and adults. Pediatr Rheumatol Online J. 2019;17(1):49.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"769_CR94","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/injr.injr_46_18","volume":"13","author":"S Surendran","year":"2018","unstructured":"Surendran S, Balan S. Clinical profile and treatment outcome in chronic recurrent multifocal osteomyelitis: experience from a tertiary care center in Southern India. Indian J Rheumatol. 2018;13(4):240\u20135.","journal-title":"Indian J Rheumatol."},{"issue":"6","key":"769_CR95","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jbspin.2019.06.005","volume":"86","author":"J Su\u0142ko","year":"2019","unstructured":"Su\u0142ko J, Ebisz M, Bie\u0144 S, B\u0142a\u017ckiewicz M, Jurczyk M, Namy\u015blak M. Treatment of chronic recurrent multifocal osteomyelitis with bisphosphonates in children. Jt Bone Spine. 2019;86(6):783\u20138.","journal-title":"Jt Bone Spine"},{"issue":"4","key":"769_CR96","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5152\/eurjrheum.2015.0020","volume":"2","author":"S Wintrich","year":"2015","unstructured":"Wintrich S, Horneff G. Characteristics and outcomes of chronic non-bacterial osteitis in children. Eur J Rheumatol. 2015;2(4):139\u201342.","journal-title":"Eur J Rheumatol"},{"issue":"4","key":"769_CR97","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/art.39013","volume":"67","author":"J Wipff","year":"2015","unstructured":"Wipff J, Costantino F, Lemelle I, Pajot C, Duquesne A, Lorrot M, et al. A large national cohort of French patients with chronic recurrent multifocal osteitis. Arthritis Rheumatol. 2015;67(4):1128\u201337.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"769_CR98","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3899\/jrheum.141138","volume":"42","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Chauvin NA, Jaramillo D, Burnham JM. Aggressive therapy reduces disease activity without skeletal damage progression in chronic nonbacterial osteomyelitis. J Rheumatol. 2015;42(7):1245\u201351.","journal-title":"J Rheumatol"},{"key":"769_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860646","volume":"13","author":"M Zhao","year":"2022","unstructured":"Zhao M, Wu D, Yu K, Shen M. Clinical and genetic features of Chinese adult patients with chronic non-bacterial osteomyelitis: a single center report. Front Immunol. 2022;13:860646.","journal-title":"Front Immunol"},{"issue":"1","key":"769_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00657-4","volume":"20","author":"L Ma","year":"2022","unstructured":"Ma L, Liu H, Tang H, Zhang Z, Zou L, Yu H, et al. Clinical characteristics and outcomes of chronic nonbacterial osteomyelitis in children: a multicenter case series. Pediatr Rheumatol Online J. 2022;20(1):1.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"10","key":"769_CR101","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3899\/jrheum.2022-1323","volume":"50","author":"EY Wu","year":"2023","unstructured":"Wu EY, Oliver M, Scheck J, Lapidus S, Akca UK, Yasin S, et al. Feasibility of conducting comparative effectiveness research and validation of a clinical disease activity score for chronic nonbacterial osteomyelitis. J Rheumatol. 2023;50(10):1333\u201340.","journal-title":"J Rheumatol"},{"issue":"5","key":"769_CR102","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10875-009-9316-6","volume":"29","author":"T Nakashima","year":"2009","unstructured":"Nakashima T, Takayanagi H, Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol. 2009;29(5):555\u201367.","journal-title":"J Clin Immunol"},{"issue":"2","key":"769_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2020.105120","volume":"88","author":"J Bustamante","year":"2021","unstructured":"Bustamante J, Murias S, Enriquez E, Alcobendas R, Remesal A, De Inocencio J. Biological therapy in refractory chronic nonbacterial osteomyelitis: a case series of 19 patients. Jt Bone Spine. 2021;88(2):105120.","journal-title":"Jt Bone Spine"},{"issue":"8","key":"769_CR104","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jdcr.2018.06.008","volume":"4","author":"JA Campbell","year":"2018","unstructured":"Campbell JA, Kodama SS, Gupta D, Zhao Y. Case series of psoriasis associated with tumor necrosis factor-\u03b1 inhibitors in children with chronic recurrent multifocal osteomyelitis. JAAD Case Rep. 2018;4(8):767\u201371.","journal-title":"JAAD Case Rep"},{"key":"769_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109018","volume":"238","author":"A Schnabel","year":"2022","unstructured":"Schnabel A, Nashawi M, Anderson C, Felsenstein S, Lamoudi M, Poole-Cowley J, et al. TNF-inhibitors or bisphosphonates in chronic nonbacterial osteomyelitis? Results of an international retrospective multicenter study. Clin Immunol. 2022;238:109018.","journal-title":"Clin Immunol"},{"issue":"8","key":"769_CR106","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/rheumatology\/keq122","volume":"49","author":"D Eleftheriou","year":"2010","unstructured":"Eleftheriou D, Gerschman T, Sebire N, Woo P, Pilkington CA, Brogan PA. Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood. Rheumatology (Oxford). 2010;49(8):1505\u201312.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"769_CR107","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40272-023-00581-y","volume":"25","author":"C Yang","year":"2023","unstructured":"Yang C, Rosenwasser N, Wang X, Xu Z, Scheck J, Boos MD, et al. Golimumab in children with chronic recurrent multifocal osteomyelitis: a case series and review of the literature. Paediatr Drugs. 2023;25(5):603\u201311.","journal-title":"Paediatr Drugs"},{"issue":"1","key":"769_CR108","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1093\/mrcr\/rxae038","volume":"9","author":"C Kruger","year":"2025","unstructured":"Kruger C, Wang C, Grim A. Paediatric SAPHO syndrome with pleural effusion: case report of a unique finding in a rare disease. Mod Rheumatol Case Rep. 2025;9(1):168\u201373.","journal-title":"Mod Rheumatol Case Rep"},{"issue":"2","key":"769_CR109","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/acr.24100","volume":"73","author":"LH Buckley","year":"2021","unstructured":"Buckley LH, Xiao R, Perman MJ, Grossman AB, Weiss PF. Psoriasis associated with tumor necrosis factor inhibitors in children with inflammatory diseases. Arthritis Care Res (Hoboken). 2021;73(2):215\u201320.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"769_CR110","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/1744666X.2023.2218088","volume":"19","author":"S Singhal","year":"2023","unstructured":"Singhal S, Landes C, Shukla R, McCann LJ, Hedrich CM. Classification and management strategies for paediatric chronic nonbacterial osteomyelitis and chronic recurrent multifocal osteomyelitis. Expert Rev Clin Immunol. 2023;19(9):1101\u201316.","journal-title":"Expert Rev Clin Immunol"},{"issue":"11","key":"769_CR111","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3899\/jrheum.181254","volume":"46","author":"CM Andreasen","year":"2019","unstructured":"Andreasen CM, Jurik AG, Glerup MB, H\u00f8st C, Mahler BT, Hauge EM, et al. Response to early-onset pamidronate reatment in chronic nonbacterial osteomyelitis: a retrospective single-center study. J Rheumatol. 2019;46(11):1515\u201323.","journal-title":"J Rheumatol"},{"issue":"1","key":"769_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-019-0340-7","volume":"17","author":"CS Bhat","year":"2019","unstructured":"Bhat CS, Roderick M, Sen ES, Finn A, Ramanan AV. Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity. Pediatr Rheumatol Online J. 2019;17(1):35.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"769_CR113","first-page":"707","volume":"35","author":"H Gleeson","year":"2008","unstructured":"Gleeson H, Wiltshire E, Briody J, Hall J, Chaitow J, Sillence D, et al. Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape. J Rheumatol. 2008;35(4):707\u201312.","journal-title":"J Rheumatol"},{"issue":"4","key":"769_CR114","first-page":"604","volume":"32","author":"C Hofmann","year":"2014","unstructured":"Hofmann C, Wurm M, Schwarz T, Neubauer H, Beer M, Girschick H, et al. A standardized clinical and radiological follow-up of patients with chronic non-bacterial osteomyelitis treated with pamidronate. Clin Exp Rheumatol. 2014;32(4):604\u20139.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"769_CR115","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00431-010-1188-5","volume":"169","author":"T Hospach","year":"2010","unstructured":"Hospach T, Langendoerfer M, von Kalle T, Maier J, Dannecker GE. Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. Eur J Pediatr. 2010;169(9):1105\u201311.","journal-title":"Eur J Pediatr"},{"key":"769_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-7-2","volume":"7","author":"PM Miettunen","year":"2009","unstructured":"Miettunen PM, Wei X, Kaura D, Reslan WA, Aguirre AN, Kellner JD. Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J. 2009;7:2.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"769_CR117","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3899\/jrheum.200329","volume":"48","author":"J Panwar","year":"2021","unstructured":"Panwar J, Tolend M, Lim L, Tse SM, Doria AS, Laxer RM, et al. Whole-body MRI quantification for assessment of bone lesions in chronic nonbacterial osteomyelitis patients treated with pamidronate: a prevalence, reproducibility, and responsiveness study. J Rheumatol. 2021;48(5):751\u20139.","journal-title":"J Rheumatol"},{"issue":"11","key":"769_CR118","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1093\/rheumatology\/keu226","volume":"53","author":"M Roderick","year":"2014","unstructured":"Roderick M, Shah R, Finn A, Ramanan AV. Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. Rheumatology (Oxford). 2014;53(11):1973\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"769_CR119","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jpeds.2007.08.047","volume":"152","author":"PJ Simm","year":"2008","unstructured":"Simm PJ, Allen RC, Zacharin MR. Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. J Pediatr. 2008;152(4):571\u20135.","journal-title":"J Pediatr"},{"issue":"6","key":"769_CR120","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jbspin.2014.11.010","volume":"82","author":"ED Batu","year":"2015","unstructured":"Batu ED, Ergen FB, Gulhan B, Topaloglu R, Aydingoz U, Ozen S. Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO). Jt Bone Spine. 2015;82(6):471\u20133.","journal-title":"Jt Bone Spine"},{"issue":"2","key":"769_CR121","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00223-023-01154-4","volume":"114","author":"RB Jansen","year":"2024","unstructured":"Jansen RB, Nilsson J, Buch-Larsen K, Kofod T, Schwarz P. Treatment effect of zoledronic acid in chronic non-bacterial osteomyelitis of the jaw: a case series. Calcif Tissue Int. 2024;114(2):129\u201336.","journal-title":"Calcif Tissue Int"},{"key":"769_CR122","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X261446898","volume":"18","author":"A Marino","year":"2026","unstructured":"Marino A, Amati A, Di Taranto R, Pireddu D, Grillo G, Baldo F, et al. Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registry. Ther Adv Musculoskelet Dis. 2026;18:1759720X261446898.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"8","key":"769_CR123","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3899\/jrheum.160690","volume":"44","author":"M Pardeo","year":"2017","unstructured":"Pardeo M, Pires Marafon D, Messia V, Garganese MC, De Benedetti F, Insalaco A. Anakinra in a cohort of children with chronic nonbacterial osteomyelitis. J Rheumatol. 2017;44(8):1231\u20138.","journal-title":"J Rheumatol"},{"issue":"6","key":"769_CR124","doi-asserted-by":"publisher","first-page":"keaf645","DOI":"10.1093\/rheumatology\/keaf645","volume":"65","author":"V Cam","year":"2026","unstructured":"Cam V, Cingoz E, Bayindir Y, Unal D, Ercan Emreol H, Erkan MO, et al. Treatment responses and relapse predictors in pediatric CNO: insights from a referral center. Rheumatology (Oxford). 2026;65(6):keaf645.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"769_CR125","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.semarthrit.2018.04.003","volume":"48","author":"D Daoussis","year":"2019","unstructured":"Daoussis D, Konstantopoulou G, Kraniotis P, Sakkas L, Liossis SN. Biologics in SAPHO syndrome: a systematic review. Semin Arthritis Rheum. 2019;48(4):618\u201325.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"769_CR126","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1136\/annrheumdis-2011-200743","volume":"71","author":"D Wendling","year":"2012","unstructured":"Wendling D, Prati C, Aubin F. Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis. 2012;71(6):1098\u2013100.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"769_CR127","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40272-023-00615-5","volume":"26","author":"K Cetin Gedik","year":"2024","unstructured":"Cetin Gedik K, Arici ZS, Kul Cinar O, Garcia-Bournissen F, Romano M, Demirkaya E. Practical approach to diagnosis and management of IL-1-mediated autoinflammatory diseases (CAPS, TRAPS, MKD, and DIRA). Paediatr Drugs. 2024;26(2):113\u201326.","journal-title":"Paediatr Drugs"},{"issue":"7","key":"769_CR128","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1136\/annrheumdis-2021-221801","volume":"81","author":"M Romano","year":"2021","unstructured":"Romano M, Arici ZS, Piskin D, Alehashemi S, Aletaha D, Barron KS, et al. The 2021 EULAR\/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist. Ann Rheum Dis. 2021;81(7):907\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"769_CR129","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/annrheumdis-2012-201818","volume":"72","author":"T Herlin","year":"2013","unstructured":"Herlin T, Fiirgaard B, Bjerre M, Kerndrup G, Hasle H, Bing X, et al. Efficacy of anti-IL-1 treatment in Majeed syndrome. Ann Rheum Dis. 2013;72(3):410\u20133.","journal-title":"Ann Rheum Dis"},{"key":"769_CR130","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fped.2017.00256","volume":"5","author":"SR Hofmann","year":"2017","unstructured":"Hofmann SR, Bottger F, Range U, Luck C, Morbach H, Girschick HJ, et al. Serum interleukin-6 and CCL11\/eotaxin may be suitable biomarkers for the diagnosis of chronic nonbacterial osteomyelitis. Front Pediatr. 2017;5:256.","journal-title":"Front Pediatr"},{"issue":"6","key":"769_CR131","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/annrheumdis-2014-205351","volume":"74","author":"HI Brunner","year":"2015","unstructured":"Brunner HI, Ruperto N, Zuber Z, Keane C, Harari O, Kenwright A, et al. Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. Ann Rheum Dis. 2015;74(6):1110\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"769_CR132","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367(25):2385\u201395.","journal-title":"N Engl J Med"},{"issue":"6","key":"769_CR133","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/mr\/roaf045","volume":"35","author":"Y Maeda","year":"2025","unstructured":"Maeda Y, Hiejima E, Izawa K, Nishimura K, Yazawa Y, Iwata N, et al. The first nationwide epidemiological survey of chronic recurrent multifocal osteomyelitis in Japan. Mod Rheumatol. 2025;35(6):1047\u201356.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"769_CR134","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1297-319X(01)00276-7","volume":"68","author":"C Job-Deslandre","year":"2001","unstructured":"Job-Deslandre C, Krebs S, Kahan A. Chronic recurrent multifocal osteomyelitis: five-year outcomes in 14 pediatric cases. Jt Bone Spine. 2001;68(3):245\u201351.","journal-title":"Jt Bone Spine"},{"issue":"1","key":"769_CR135","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12969-023-00826-7","volume":"21","author":"D O'Leary","year":"2023","unstructured":"O\u2019Leary D, Al Julandani DA, Zia M, Klotsche J, Minden K, Roderick M, et al. HLA-B*27 is associated with CNO in a European cohort. Pediatr Rheumatol Online J. 2023;21(1):52.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"769_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-025-01106-2","volume":"23","author":"C Hofmann","year":"2025","unstructured":"Hofmann C, Holl-Wieden A, Reiser C, Beer M, Raab P, Morbach H, et al. Chronic non-bacterial osteomyelitis in children- five-year standardized follow-up of a prospective observational cohort in the pre-biological era. Pediatr Rheumatol Online J. 2025;23(1):50.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"769_CR137","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40884","volume":"71","author":"S Ringold","year":"2019","unstructured":"Ringold S, Angeles-Han ST, Beukelman T, Lovell D, Cuello CA, Becker ML, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the treatment of juvenile idiopathic arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthritis Rheumatol. 2019;71(6):846\u201363.","journal-title":"Arthritis Rheumatol"},{"issue":"9563","key":"769_CR138","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767\u201378.","journal-title":"Lancet"},{"issue":"3","key":"769_CR139","first-page":"67","volume":"2012","author":"PF Weiss","year":"2012","unstructured":"Weiss PF. Diagnosis and treatment of enthesitis-related arthritis. Adolesc Health Med Ther. 2012;2012(3):67\u201374.","journal-title":"Adolesc Health Med Ther"},{"issue":"5","key":"769_CR140","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/annrheumdis-2011-201060","volume":"72","author":"MH Otten","year":"2013","unstructured":"Otten MH, Prince FH, Anink J, Ten Cate R, Hoppenreijs EP, Armbrust W, et al. Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register. Ann Rheum Dis. 2013;72(5):721\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"769_CR141","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1136\/ard.61.10.941","volume":"61","author":"R Burgos-Vargas","year":"2002","unstructured":"Burgos-Vargas R, Vazquez-Mellado J, Pacheco-Tena C, Hernandez-Garduno A, Goycochea-Robles MV. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies. Ann Rheum Dis. 2002;61(10):941\u20132.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"769_CR142","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/acr.22657","volume":"67","author":"R Burgos-Vargas","year":"2015","unstructured":"Burgos-Vargas R, Tse SM, Horneff G, Pangan AL, Kalabic J, Goss S, et al. A randomized, double-blind, placebo-controlled multicenter study of adalimumab in pediatric patients with enthesitis-related arthritis. Arthritis Care Res (Hoboken). 2015;67(11):1503\u201312.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"769_CR143","volume":"2","author":"G Cagnotto","year":"2025","unstructured":"Cagnotto G, Juhl CB, Ahlstrom F, Wikstrom F, Bruschettini M, Petersson I, et al. Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis. Cochrane Database Syst Rev. 2025;2(2):CD013715.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"769_CR144","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/ard-2022-222849","volume":"82","author":"HI Brunner","year":"2023","unstructured":"Brunner HI, Foeldvari I, Alexeeva E, Ayaz NA, Calvo Penades I, Kasapcopur O, et al. Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. Ann Rheum Dis. 2023;82(1):154\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"10315","key":"769_CR145","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1016\/S0140-6736(21)01255-1","volume":"398","author":"N Ruperto","year":"2021","unstructured":"Ruperto N, Brunner HI, Synoverska O, Ting TV, Mendoza CA, Spindler A, et al. Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial. Lancet. 2021;398(10315):1984\u201396.","journal-title":"Lancet"},{"issue":"9","key":"769_CR146","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1136\/ard.2010.143347","volume":"70","author":"P Tynj\u00e4l\u00e4","year":"2011","unstructured":"Tynj\u00e4l\u00e4 P, V\u00e4h\u00e4salo P, Tarkiainen M, Kr\u00f6ger L, Aalto K, Malin M, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis. 2011;70(9):1605\u201312.","journal-title":"Ann Rheum Dis"},{"key":"769_CR147","unstructured":"American College of Rheumatology. 2026 Update of the American College of Rheumatology. Recommendations for the treatment of axial spondyloarthritis in adults and children\/adolescents. ACR Guideline Summary. 2026. https:\/\/assets.contentstack.io\/v3\/assets\/bltee37abb6b278ab2c\/blt424f1e71604af245\/axspa-guideline-summary-2026.pdf. Accessed 16 Aug 2026."},{"issue":"1","key":"769_CR148","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-025-05594-9","volume":"25","author":"L Ge","year":"2025","unstructured":"Ge L, Gao Y, Chen X, Guo J, Zhang D, Yang Y. Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis. BMC Pediatr. 2025;25(1):242.","journal-title":"BMC Pediatr"},{"issue":"9","key":"769_CR149","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1136\/ard-2023-223937","volume":"82","author":"S Ramiro","year":"2022","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. Response to: correspondence on \u201cASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update\u201d by Braun et al. Ann Rheum Dis. 2022;82(9):e206.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"769_CR150","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cei.12782","volume":"184","author":"HM Walters","year":"2016","unstructured":"Walters HM, Pan N, Lehman TJ, Adams A, Kalliolias GD, Zhu YS, et al. The impact of disease activity and tumour necrosis factor-alpha inhibitor therapy on cytokine levels in juvenile idiopathic arthritis. Clin Exp Immunol. 2016;184(3):308\u201317.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"769_CR151","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s10620-015-4007-z","volume":"61","author":"A O'Toole","year":"2016","unstructured":"O\u2019Toole A, Lucci M, Korzenik J. Inflammatory bowel disease provoked by etanercept: report of 443 possible cases combined from an IBD referral center and the FDA. Dig Dis Sci. 2016;61(6):1772\u20134.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"769_CR152","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/jpn3.70097","volume":"81","author":"EA Wine","year":"2025","unstructured":"Wine EA, Aloi M, Van Biervliet S, Bronsky J, di Carpi JM, Gasparetto M, et al. Management of paediatric ulcerative colitis, part 1: ambulatory care. An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn\u2019s and Colitis Organisation. J Pediatr Gastroenterol Nutr. 2025;81(3):765\u2013815.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"769_CR153","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","volume":"8","author":"FM Ruemmele","year":"2014","unstructured":"Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, et al. Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn\u2019s disease. J Crohns Colitis. 2014;8(10):1179\u2013207.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"769_CR154","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2016","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, Van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2016;76(6):978\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"26","key":"769_CR155","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med. 2015;373(26):2534\u201348.","journal-title":"N Engl J Med"},{"issue":"33","key":"769_CR156","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030065","volume":"101","author":"Q Ji","year":"2022","unstructured":"Ji Q, Wang Q, Pan W, Hou Y, Wang X, Bian L, et al. Exceptional response of skin symptoms to secukinumab treatment in a patient with SAPHO syndrome: case report and literature review. Medicine (Baltimore). 2022;101(33):e30065.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"769_CR157","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","volume":"61","author":"W Hueber","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn\u2019s disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012;61(12):1693\u2013700.","journal-title":"Gut"},{"issue":"10","key":"769_CR158","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/ecco-jcc\/jjx082","volume":"11","author":"O Ledder","year":"2017","unstructured":"Ledder O, Assa A, Levine A, Escher JC, de Ridder L, Ruemmele F, et al. Vedolizumab in paediatric inflammatory bowel disease: a retrospective multi-centre experience from the Paediatric IBD Porto Group of ESPGHAN. J Crohns Colitis. 2017;11(10):1230\u20137.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"769_CR159","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003688","volume":"9","author":"SWS Li","year":"2023","unstructured":"Li SWS, Roberts E, Hedrich CM. Treatment and monitoring of SAPHO syndrome: a systematic review. RMD Open. 2023;9(4):e003688.","journal-title":"RMD Open"},{"issue":"3","key":"769_CR160","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1093\/rheumatology\/keac461","volume":"62","author":"A Lanis","year":"2023","unstructured":"Lanis A, Van Den Bogaerde S, Zhao Y. Chronic recurrent multifocal osteomyelitis and tofacitinib: a case series. Rheumatology (Oxford). 2023;62(3):e42\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"769_CR161","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40272-022-00533-y","volume":"24","author":"JH Leu","year":"2022","unstructured":"Leu JH, Shiff NJ, Clark M, Bensley K, Lomax KG, Berezny K, et al. Intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis and subcutaneous ustekinumab in patients with juvenile psoriatic arthritis: extrapolation of data from studies in adults and adjacent pediatric populations. Paediatr Drugs. 2022;24(6):699\u2013714.","journal-title":"Paediatr Drugs"},{"key":"769_CR162","doi-asserted-by":"crossref","unstructured":"Benson JM, Perritt D, Scallon BJ, Heavner GA, Shealy DJ, Giles-Komar JM, et al. Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders. mAbs. 2011;3(6):535\u201345.","DOI":"10.4161\/mabs.3.6.17815"},{"issue":"2","key":"769_CR163","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10067-025-07870-6","volume":"45","author":"N \u00d6ner","year":"2026","unstructured":"\u00d6ner N, C\u00fcceo\u011flu MK, K\u00f6nte EK, Kayhan E, \u00c7akan M, Demir S, et al. Cutaneous manifestations of autoinflammatory bone diseases: a retrospective multicenter study. Clin Rheumatol. 2026;45(2):1245\u201356.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"769_CR164","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/0049-0172(88)90011-X","volume":"17","author":"RM Laxer","year":"1988","unstructured":"Laxer RM, Shore AD, Manson D, King S, Silverman ED, Wilmot DM. Chronic recurrent multifocal osteomyelitis and psoriasis: a report of a new association and review of related disorders. Semin Arthritis Rheum. 1988;17(4):260\u201370.","journal-title":"Semin Arthritis Rheum"},{"issue":"2 Pt 2","key":"769_CR165","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0190-9622(94)70176-8","volume":"31","author":"NS Prose","year":"1994","unstructured":"Prose NS, Fahrner LJ, Miller CR, Layfield L. Pustular psoriasis with chronic recurrent multifocal osteomyelitis and spontaneous fractures. J Am Acad Dermatol. 1994;31(2 Pt 2):376\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"769_CR166","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jaad.2016.08.012","volume":"76","author":"G Brown","year":"2017","unstructured":"Brown G, Wang E, Leon A, Huynh M, Wehner M, Matro R, et al. Tumor necrosis factor-\u03b1 inhibitor-induced psoriasis: systematic review of clinical features, histopathological findings, and management experience. J Am Acad Dermatol. 2017;76(2):334\u201341.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"769_CR167","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/ard.40.6.547","volume":"40","author":"H Sonozaki","year":"1981","unstructured":"Sonozaki H, Mitsui H, Miyanaga Y, Okitsu K, Igarashi M, Hayashi Y, et al. Clinical features of 53 cases with pustulotic arthro-osteitis. Ann Rheum Dis. 1981;40(6):547\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"769_CR168","first-page":"37","volume":"159","author":"K Bergdahl","year":"1979","unstructured":"Bergdahl K, Bj\u00f6rkst\u00e9n B, Gustavson K, Liden S, Probst F. Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatology (Basel). 1979;159(1):37\u201345.","journal-title":"Dermatology (Basel)"},{"issue":"2","key":"769_CR169","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0022-3476(78)80501-0","volume":"93","author":"B Bj\u00f6rkst\u00e9n","year":"1978","unstructured":"Bj\u00f6rkst\u00e9n B, Gustavson K-H, Nordstr\u00f6m S, Eriksson B, Lindholm k. Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris. J Pediatr. 1978;93(2):227\u201331.","journal-title":"J Pediatr"},{"issue":"1","key":"769_CR170","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1302\/0301-620X.70B1.3276698","volume":"70","author":"K Kawai","year":"1988","unstructured":"Kawai K, Doita M, Tateishi H, Hirohata K. Bone and joint lesions associated with pustulosis palmaris et plantaris: a clinical and histological study. J Bone Jt Surg Br. 1988;70(1):117\u201322.","journal-title":"J Bone Jt Surg Br"},{"issue":"2","key":"769_CR171","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1067\/mpd.2002.126457","volume":"141","author":"AM Huber","year":"2002","unstructured":"Huber AM, Lam PY, Duffy CM, Yeung RS, Ditchfield M, Laxer D, et al. Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr. 2002;141(2):198\u2013203.","journal-title":"J Pediatr"},{"issue":"6","key":"769_CR172","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1525-1470.1998.tb01389.x","volume":"15","author":"CJ Omidi","year":"1998","unstructured":"Omidi CJ, Siegfried EC. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient. Pediatr Dermatol. 1998;15(6):435\u20138.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"769_CR173","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1525-1470.1995.tb00122.x","volume":"12","author":"O Dagan","year":"1995","unstructured":"Dagan O, Barak Y, Metzker A. Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol. 1995;12(1):39\u201342.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"769_CR174","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0049-0172(99)80027-4","volume":"29","author":"G Hayem","year":"1999","unstructured":"Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum. 1999;29(3):159\u201371.","journal-title":"Semin Arthritis Rheum"},{"key":"769_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152277","volume":"63","author":"C Matucci-Cerinic","year":"2023","unstructured":"Matucci-Cerinic C, Malattia C, Pistorio A, Rosina S, Consolaro A, Viola S, et al. Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome. Semin Arthritis Rheum. 2023;63:152277.","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"769_CR176","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1093\/rheumatology\/keaf065","volume":"64","author":"C Matucci-Cerinic","year":"2025","unstructured":"Matucci-Cerinic C, Attico A, Malattia C, Consolaro A, Rosina S, Breda L, et al. Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric study. Rheumatology (Oxford). 2025;64(6):3777\u201386.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"769_CR177","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s10067-019-04904-8","volume":"39","author":"Y Li","year":"2020","unstructured":"Li Y, Li C, Wu N, Li F, Wu Z, Sun X, et al. Demographic, clinical, and scintigraphic comparison of patients affected by palmoplantar pustulosis and severe acne: a retrospective study. Clin Rheumatol. 2020;39(6):1989\u201396.","journal-title":"Clin Rheumatol"},{"issue":"4","key":"769_CR178","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s10067-020-05393-w","volume":"40","author":"N Wu","year":"2021","unstructured":"Wu N, Shao Y, Huo J, Zhang Y, Cao Y, Jing H, et al. Clinical characteristics of pediatric synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome: the first Chinese case series from a single center. Clin Rheumatol. 2021;40(4):1487\u201395.","journal-title":"Clin Rheumatol"},{"key":"769_CR179","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2024.152374","volume":"65","author":"XJ Shi","year":"2024","unstructured":"Shi XJ, Wang L, Ding YH, Hou XJ, Li C. Precision management in SAPHO syndrome: stratified care based on various skin manifestations. Semin Arthritis Rheum. 2024;65:152374.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"769_CR180","first-page":"112","volume":"27","author":"M Colina","year":"2009","unstructured":"Colina M, La Corte R, Trotta F. Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature. Clin Exp Rheumatol. 2009;27(1):112\u20135.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"769_CR181","first-page":"1263","volume":"38","author":"N Wu","year":"2020","unstructured":"Wu N, Zhao Y, Tao W, Wu Z, Li C, Li L. A single cohort, open-label study of the efficacy of pamidronate for palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome. Clin Exp Rheumatol. 2020;38(6):1263\u20134.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"769_CR182","first-page":"17286","volume":"36","author":"J Wro\u0144ski","year":"2026","unstructured":"Wro\u0144ski J, Adamska A, Urba J, Fory\u015b A, Kudraszewska E. Biological and targeted synthetic treatment of SAPHO syndrome: systematic literature review. Pol Arch Intern Med. 2026;36(5):17286.","journal-title":"Pol Arch Intern Med."},{"issue":"8","key":"769_CR183","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.3899\/jrheum.091086","volume":"37","author":"K Ben Abdelghani","year":"2010","unstructured":"Ben Abdelghani K, Dran DG, Gottenberg JE, Morel J, Sibilia J, Combe B. Tumor necrosis factor-alpha blockers in SAPHO syndrome. J Rheumatol. 2010;37(8):1699\u2013704.","journal-title":"J Rheumatol"},{"issue":"2","key":"769_CR184","first-page":"185","volume":"69","author":"A De Souza","year":"2011","unstructured":"De Souza A, Solomon GE, Strober BE. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate. Bull NYU Hosp Jt Dis. 2011;69(2):185\u20137.","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"2","key":"769_CR185","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clindermatol.2020.10.016","volume":"39","author":"S Garcovich","year":"2021","unstructured":"Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: the autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol. 2021;39(2):240\u20137.","journal-title":"Clin Dermatol"},{"issue":"Suppl. 6","key":"769_CR186","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jdv.15849","volume":"33","author":"G Genovese","year":"2019","unstructured":"Genovese G, Caorsi R, Moltrasio C, Marzano AV. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate. J Eur Acad Dermatol Venereol. 2019;33(Suppl. 6):40\u20131.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10275","key":"769_CR187","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi K, Balato A, Enerb\u00e4ck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397(10275):754\u201366.","journal-title":"Lancet"},{"issue":"3","key":"769_CR188","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","volume":"17","author":"W Gulliver","year":"2016","unstructured":"Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17(3):343\u201351.","journal-title":"Rev Endocr Metab Disord"},{"issue":"6","key":"769_CR189","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/rheumatology\/kei221","volume":"45","author":"A Massara","year":"2006","unstructured":"Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford). 2006;45(6):730\u20133.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"769_CR190","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ijd.13740","volume":"57","author":"DA Vekic","year":"2018","unstructured":"Vekic DA, Woods J, Lin P, Cains GD. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature. Int J Dermatol. 2018;57(1):10\u20138.","journal-title":"Int J Dermatol"},{"key":"769_CR191","doi-asserted-by":"publisher","first-page":"1134939","DOI":"10.3389\/fmed.2023.1134939","volume":"10","author":"B Chen","year":"2023","unstructured":"Chen B, Li W, Qu B. Practical aspects of the diagnosis and management of pyoderma gangrenosum. Front Med (Lausanne). 2023;10:1134939.","journal-title":"Front Med (Lausanne)."},{"key":"769_CR192","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CCID.S454057","volume":"17","author":"D Fan","year":"2024","unstructured":"Fan D, Li F, Liu Z, Tang Z, Lv S. Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome and paradoxical psoriasis with secukinumab: a case report. Clin Cosmet Investig Dermatol. 2024;17:547\u201352.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"Suppl. 3","key":"769_CR193","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljaf465.016","volume":"193","author":"J Sofela","year":"2025","unstructured":"Sofela J, Cookson H. P08 A case of a 7-year-old female with SAPHO and CRMO treated successfully with IL-17A inhibitor after failure with Anti-TNF\u03b1 biologic. Br J Dermatol. 2025;193(Suppl. 3):ljaf465.016.","journal-title":"Br J Dermatol"},{"issue":"1","key":"769_CR194","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/rheumatology\/keaa352","volume":"60","author":"B Sun","year":"2021","unstructured":"Sun B, Cao Y, Wang L, Wang M, Li C. Successful treatment of refractory mandibular lesions in SAPHO syndrome with secukinumab. Rheumatology (Oxford). 2021;60(1):473\u20134.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"769_CR195","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13030516","volume":"13","author":"W Tu","year":"2023","unstructured":"Tu W, Nie D, Chen Y, Wen C, Zeng Z. Successful treatment of SAPHO syndrome complicated with ankylosing spondylitis by secukinumab: a case report. J Pers Med. 2023;13(3):516.","journal-title":"J Pers Med"},{"issue":"6","key":"769_CR196","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3899\/jrheum.201260","volume":"48","author":"L Wang","year":"2021","unstructured":"Wang L, Sun B, Li C. Clinical and radiological remission of osteoarticular and cutaneous lesions in SAPHO patients treated with secukinumab: a case series. J Rheumatol. 2021;48(6):953\u20135.","journal-title":"J Rheumatol"},{"issue":"10","key":"769_CR197","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.70101","volume":"7","author":"P Fazeli","year":"2025","unstructured":"Fazeli P, Bahramian S, Farahmand K, Ghoshouni H, Farahmand Y, Soheili A, et al. JAK inhibitors for treatment of SAPHO syndrome: a systematic review of 72 cases. ACR Open Rheumatol. 2025;7(10):e70101.","journal-title":"ACR Open Rheumatol."},{"key":"769_CR198","doi-asserted-by":"publisher","first-page":"adv44265","DOI":"10.2340\/actadv.v105.44265","volume":"105","author":"D Narayanan","year":"2025","unstructured":"Narayanan D, Tran T, Duque-Clavijo V, Doan HQ, Tyring SK. Successful treatment of comorbid SAPHO syndrome and hidradenitis suppurativa with upadacitinib. Acta Derm Venereol. 2025;105:adv44265.","journal-title":"Acta Derm Venereol"},{"issue":"29","key":"769_CR199","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.3748\/wjg.v29.i29.4481","volume":"29","author":"LF Wang","year":"2023","unstructured":"Wang LF, Chen PR, He SK, Duan SH, Zhang Y. Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: a literature review. World J Gastroenterol. 2023;29(29):4481\u201398.","journal-title":"World J Gastroenterol"},{"key":"769_CR200","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.2147\/JIR.S353539","volume":"15","author":"W Cheng","year":"2022","unstructured":"Cheng W, Li F, Tian J, Xie X, Chen JW, Peng XF, et al. New insights in the treatment of SAPHO syndrome and medication recommendations. J Inflamm Res. 2022;15:2365\u201380.","journal-title":"J Inflamm Res"},{"issue":"4","key":"769_CR201","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/annrheumdis-2018-214273","volume":"78","author":"S Schreiber","year":"2019","unstructured":"Schreiber S, Colombel JF, Feagan BG, Reich K, Deodhar AA, McInnes IB, et al. Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trials. Ann Rheum Dis. 2019;78(4):473\u20139.","journal-title":"Ann Rheum Dis"},{"key":"769_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1728245","volume":"17","author":"Y Liu","year":"2026","unstructured":"Liu Y, Jin D, Li W, Zhang S, Li C, Li X. Case report: upadacitinib for SAPHO syndrome with biologics-induced paradoxical manifestation and hyperimmunoglobulinemia E. Front Immunol. 2026;17:1728245.","journal-title":"Front Immunol"},{"key":"769_CR203","doi-asserted-by":"publisher","first-page":"1662675","DOI":"10.3389\/fimmu.2025.1662675","volume":"16","author":"Y Yang","year":"2025","unstructured":"Yang Y, Sun Z, Ge Y. Upadacitinib in the treatment of SAPHO syndrome: a case report. Front Immunol. 2025;16:1662675.","journal-title":"Front Immunol"},{"issue":"1","key":"769_CR204","doi-asserted-by":"publisher","first-page":"2437259","DOI":"10.1080\/09546634.2024.2437259","volume":"35","author":"Z Lin","year":"2024","unstructured":"Lin Z, Piao S, Zhang R, Yu C, Hou Z, Wang A. Successful treatment of SAPHO syndrome with oral abrocitinib: a case report. J Dermatolog Treat. 2024;35(1):2437259.","journal-title":"J Dermatolog Treat"},{"key":"769_CR205","doi-asserted-by":"publisher","first-page":"1476793","DOI":"10.3389\/fmed.2024.1476793","volume":"11","author":"N Du","year":"2024","unstructured":"Du N, Yang J, Zhang Y, Lv X, Cao L, Min W. Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients. Front Med (Lausanne). 2024;11:1476793.","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"769_CR206","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s002560050091","volume":"25","author":"M Sundaram","year":"1996","unstructured":"Sundaram M, McDonald D, Engel E, Rotman M, Siegfried EC. Chronic recurrent multifocal osteomyelitis: an evolving clinical and radiological spectrum. Skeletal Radiol. 1996;25(4):333\u20136.","journal-title":"Skeletal Radiol"},{"issue":"3","key":"769_CR207","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1046\/j.1525-1470.1999.00058.x","volume":"16","author":"LD Nurre","year":"1999","unstructured":"Nurre LD, Rabalais GP, Callen JP. Neutrophilic dermatosis-associated sterile chronic multifocal osteomyelitis in pediatric patients: case report and review. Pediatr Dermatol. 1999;16(3):214\u20136.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"769_CR208","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1046\/j.1365-2133.2002.48665.x","volume":"147","author":"D Williamson","year":"2002","unstructured":"Williamson D, Sibbald RG. Chronic recurrent multifocal osteomyelitis: a rare association with pyoderma gangrenosum in adults. Br J Dermatol. 2002;147(3):611.","journal-title":"Br J Dermatol"},{"issue":"2","key":"769_CR209","doi-asserted-by":"publisher","first-page":"159","DOI":"10.24953\/turkjpediatr.2006.2620","volume":"48","author":"G Koturo\u011flu","year":"2006","unstructured":"Koturo\u011flu G, Vardar F, Ozkinay F, Kurug\u00f6l Z, Akalin T, Ozkinay C. Pyoderma gangrenosum in a six-month-old boy. Turk J Pediatr. 2006;48(2):159\u201361.","journal-title":"Turk J Pediatr"},{"issue":"1","key":"769_CR210","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-016-0275-z","volume":"16","author":"MC Wurm","year":"2016","unstructured":"Wurm MC, Brecht I, Lell M, Brunner K, Mitsimponas KT, Chada M, et al. Chronic recurrent multifocal osteomyelitis in association with pyoderma gangraenosum. BMC Oral Health. 2016;16(1):85.","journal-title":"BMC Oral Health"},{"issue":"8","key":"769_CR211","doi-asserted-by":"publisher","first-page":"e283","DOI":"10.1111\/1346-8138.15417","volume":"47","author":"K Katsuo","year":"2020","unstructured":"Katsuo K, Honda T, Kaku Y, Nishitani-Isa M, Honda Y, Yasumi T, et al. Pyoderma gangrenosum associated with chronic recurrent multifocal osteomyelitis as a possible paradoxical reaction to anti-tumor necrosis factor-\u03b1 therapy. J Dermatol. 2020;47(8):e283\u20134.","journal-title":"J Dermatol"},{"key":"769_CR212","doi-asserted-by":"publisher","first-page":"1197273","DOI":"10.3389\/fmed.2023.1197273","volume":"10","author":"M Romagnuolo","year":"2023","unstructured":"Romagnuolo M, Moltrasio C, Iannone C, Gattinara M, Cambiaghi S, Marzano AV. Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report. Front Med (Lausanne). 2023;10:1197273.","journal-title":"Front Med (Lausanne)."},{"issue":"2","key":"769_CR213","first-page":"133","volume":"315","author":"M Bognar","year":"1998","unstructured":"Bognar M, Blake W, Agudelo C. Chronic recurrent multifocal osteomyelitis associated with Crohn\u2019s disease. Am J Med Sci. 1998;315(2):133\u20135.","journal-title":"Am J Med Sci"},{"issue":"2","key":"769_CR214","first-page":"91","volume":"59","author":"MF Kahn","year":"1992","unstructured":"Kahn MF, Bouchon JP, Chamot AM, Palazzo E. Chronic enterocolopathies and SAPHO syndrome. 8 cases. Rev Rhum Mal Osteoartic. 1992;59(2):91\u20134.","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"12","key":"769_CR215","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1023\/A:1026695224019","volume":"44","author":"A Bousvaros","year":"1999","unstructured":"Bousvaros A, Marcon M, Treem W, Waters P, Issenman R, Couper R, et al. Chronic recurrent multifocal osteomyelitis associated with chronic inflammatory bowel disease in children. Dig Dis Sci. 1999;44(12):2500\u20137.","journal-title":"Dig Dis Sci"},{"issue":"7","key":"769_CR216","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/rheumatology\/key058","volume":"57","author":"H Girschick","year":"2018","unstructured":"Girschick H, Finetti M, Orlando F, Schalm S, Insalaco A, Ganser G, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology (Oxford). 2018;57(7):1203\u201311.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"769_CR217","doi-asserted-by":"publisher","first-page":"4","DOI":"10.21037\/tp.2019.01.06","volume":"8","author":"H-J Jang","year":"2019","unstructured":"Jang H-J, Kang B, Choe B-H. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr. 2019;8(1):4\u201315.","journal-title":"Transl Pediatr"},{"issue":"1","key":"769_CR218","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ibd.20604","volume":"15","author":"FA Jose","year":"2009","unstructured":"Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(1):63\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"769_CR219","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","volume":"10","author":"M Harbord","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239\u201354.","journal-title":"J Crohns Colitis"},{"issue":"9","key":"769_CR220","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/2050640620958902","volume":"8","author":"FM Jansen","year":"2020","unstructured":"Jansen FM, Vavricka SR, den Broeder AA, de Jong EM, Hoentjen F, van Dop WA. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United Eur Gastroenterol J. 2020;8(9):1031\u201344.","journal-title":"United Eur Gastroenterol J"},{"issue":"2","key":"769_CR221","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjaf007","volume":"19","author":"M Malmquist","year":"2002","unstructured":"Malmquist M, Voghera S, Berg S, Saalman R, Ol\u00e9n O. Childhood-onset inflammatory bowel disease and chronic non-bacterial osteomyelitis: a Swedish nationwide cohort study 2002-2022. J Crohns Colitis. 2002;19(2):jjaf007.","journal-title":"J Crohns Colitis"},{"key":"769_CR222","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7694942","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Dedeoglu F, Ferguson PJ, Lapidus SK, Laxer RM, Bradford MC, et al. Physicians\u2019 perspectives on the diagnosis and treatment of chronic nonbacterial osteomyelitis. Int J Rheumatol. 2017. https:\/\/doi.org\/10.1155\/2017\/7694942.","journal-title":"Int J Rheumatol"},{"issue":"8","key":"769_CR223","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/j.1572-0241.2000.02262.x","volume":"95","author":"JB Felder","year":"2000","unstructured":"Felder JB, Korelitz BI, Rajapakse R, Schwarz S, Horatagis AP, Gleim G. Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol. 2000;95(8):1949\u201354.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"769_CR224","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1111\/apt.14606","volume":"47","author":"OO Moninuola","year":"2018","unstructured":"Moninuola OO, Milligan W, Lochhead P, Khalili H. Systematic review with meta-analysis: association between acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs) and risk of Crohn\u2019s disease and ulcerative colitis exacerbation. Aliment Pharmacol Ther. 2018;47(11):1428\u201339.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"769_CR225","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1111\/j.1572-0241.2008.01807.x","volume":"103","author":"EI Benchimol","year":"2008","unstructured":"Benchimol EI, Turner D, Mann EH, Thomas KE, Gomes T, McLernon RA, et al. Toxic megacolon in children with inflammatory bowel disease: clinical and radiographic characteristics. Am J Gastroenterol. 2008;103(6):1524\u201331.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"769_CR226","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/jpn3.70096","volume":"81","author":"A Assa","year":"2025","unstructured":"Assa A, Aloi M, Van Biervliet S, Bronsky J, di Carpi JM, Gasparetto M, et al. Management of paediatric ulcerative colitis, part 2: acute severe colitis. An updated evidence-based consensus guideline from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition and the European Crohn\u2019s and Colitis Organization. J Pediatr Gastroenterol Nutr. 2025;81(3):816\u201351.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"769_CR227","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","volume":"18","author":"H Gordon","year":"2024","unstructured":"Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, et al. ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2024;18(1):1\u201337.","journal-title":"J Crohns Colitis"},{"issue":"4","key":"769_CR228","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1136\/gutjnl-2020-322129","volume":"70","author":"T Greuter","year":"2021","unstructured":"Greuter T, Rieder F, Kucharzik T, Peyrin-Biroulet L, Schoepfer AM, Rubin DT, et al. Emerging treatment options for extraintestinal manifestations in IBD. Gut. 2021;70(4):796\u2013802.","journal-title":"Gut"},{"issue":"2","key":"769_CR229","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.gastro.2012.04.046","volume":"143","author":"JS Hyams","year":"2012","unstructured":"Hyams JS, Griffiths A, Markowitz J, Baldassano RN, Faubion WA Jr, Colletti RB, et al. Safety and efficacy of adalimumab for moderate to severe Crohn\u2019s disease in children. Gastroenterology. 2012;143(2):365-74.e2.","journal-title":"Gastroenterology"},{"issue":"2","key":"769_CR230","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/ecco-jcc\/jjaa161","volume":"15","author":"PF van Rheenen","year":"2021","unstructured":"van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL, et al. The medical management of paediatric Crohn\u2019s disease: an ECCO-ESPGHAN guideline update. J Crohns Colitis. 2021;15(2):171\u201394.","journal-title":"J Crohns Colitis"},{"issue":"3","key":"769_CR231","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/j.gastro.2006.12.003","volume":"132","author":"J Hyams","year":"2007","unstructured":"Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn\u2019s disease in children. Gastroenterology. 2007;132(3):863\u201373 (quiz 1165\u20131166).","journal-title":"Gastroenterology"},{"issue":"4","key":"769_CR232","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1053\/j.gastro.2019.06.003","volume":"157","author":"A Assa","year":"2019","unstructured":"Assa A, Matar M, Turner D, Broide E, Weiss B, Ledder O, et al. Proactive monitoring of adalimumab trough concentration associated with increased clinical remission in children with Crohn\u2019s disease compared with reactive monitoring. Gastroenterology. 2019;157(4):985-96.e2.","journal-title":"Gastroenterology"},{"issue":"12","key":"769_CR233","volume":"13","author":"A Tzaneti","year":"2023","unstructured":"Tzaneti A, Athanasopoulou E, Fessatou S, Fotis L. Chronic nonbacterial osteomyelitis in inflammatory bowel disease. Life (Basel). 2023;13(12):2347.","journal-title":"Life (Basel)"},{"issue":"5","key":"769_CR234","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40272-024-00631-z","volume":"26","author":"S Cohen","year":"2024","unstructured":"Cohen S, Rolandsdotter H, Kolho K-L, Turner D, Tzivinikos C, Bramuzzo M, et al. Effectiveness and safety of ustekinumab in pediatric ulcerative colitis: a multi-center retrospective study from the Pediatric IBD Porto Group of ESPGHAN. Paediatr Drugs. 2024;26(5):609\u201317.","journal-title":"Paediatr Drugs"},{"issue":"8","key":"769_CR235","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s00431-024-05588-2","volume":"183","author":"G Pujol-Muncunill","year":"2024","unstructured":"Pujol-Muncunill G, Navas-L\u00f3pez VM, Ledder O, Cohen S, Lekar M, Turner D, et al. STEP-CD study: ustekinumab use in paediatric Crohn\u2019s disease-a multicentre retrospective study from Paediatric IBD Porto Group of ESPGHAN. Eur J Pediatr. 2024;183(8):3253\u201362.","journal-title":"Eur J Pediatr"},{"key":"769_CR236","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/acr-25-32","volume":"10","author":"A Betcher","year":"2026","unstructured":"Betcher A, Siegel R, Aggarwal K, Chen Y. Ustekinumab as a novel treatment of chronic nonbacterial osteomyelitis: a case report. AME Case Rep. 2026;10:7.","journal-title":"AME Case Rep"},{"issue":"1","key":"769_CR237","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1159\/000547522","volume":"19","author":"J Ongay","year":"2025","unstructured":"Ongay J, Candel I, Bitton A, Afif W, Bessissow T, Lakatos PL. Case report: secukinumab (interleukin-17 inhibitor) and ulcerative colitis flare: the double-edged wword. Case Rep Gastroenterol. 2025;19(1):637\u201343.","journal-title":"Case Rep Gastroenterol"},{"key":"769_CR238","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.611256","volume":"12","author":"D Noviello","year":"2021","unstructured":"Noviello D, Mager R, Roda G, Borroni RG, Fiorino G, Vetrano S. The IL23-IL17 immune axis in the treatment of ulcerative colitis: successes, defeats, and ongoing challenges. Front Immunol. 2021;12:611256.","journal-title":"Front Immunol"},{"issue":"8","key":"769_CR239","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1215734","volume":"369","author":"BG Feagan","year":"2013","unstructured":"Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel J-F, Sandborn WJ, et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2013;369(8):699\u2013710.","journal-title":"N Engl J Med"},{"issue":"8","key":"769_CR240","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1215739","volume":"369","author":"WJ Sandborn","year":"2013","unstructured":"Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel J-F, Sands BE, et al. Vedolizumab as induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med. 2013;369(8):711\u201321.","journal-title":"N Engl J Med"},{"key":"769_CR241","doi-asserted-by":"crossref","unstructured":"Turner D, Kierku\u015b J, Korczowski B, Strisciuglio C, Chen J, Takaki Y, et al. DOP037 Efficacy and safety of intravenous vedolizumab in paediatric patients with moderate-to-severe ulcerative colitis: results from the KEPLER phase 3 trial. J Crohns Colitis. 2026;20(Suppl._1).","DOI":"10.1093\/ecco-jcc\/jjaf231.074"},{"key":"769_CR242","first-page":"1449","volume":"8","author":"Y Nishiura","year":"2025","unstructured":"Nishiura Y, Tsukagoshi Y, Nozawa D, Saito H, Honma K, Hoshi T, et al. Chronic recurrent multifocal osteomyelitis associated in a child with inflammatory bowel disease and primary sclerosing cholangitis: a case report. JMA J. 2025;8:1449\u201353.","journal-title":"JMA J."},{"issue":"1","key":"769_CR243","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","volume":"15","author":"S Honap","year":"2024","unstructured":"Honap S, Agorogianni A, Colwill MJ, Mehta SK, Donovan F, Pollok R, et al. JAK inhibitors for inflammatory bowel disease: recent advances. Frontline Gastroenterol. 2024;15(1):59\u201369.","journal-title":"Frontline Gastroenterol"},{"key":"769_CR244","doi-asserted-by":"publisher","first-page":"175628482110057","DOI":"10.1177\/17562848211005708","volume":"14","author":"DT Rubin","year":"2021","unstructured":"Rubin DT, Reinisch W, Greuter T, Kotze PG, Pinheiro M, Mundayat R, et al. Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis. Ther Adv Gastroenterol. 2021;14:17562848211005708.","journal-title":"Ther Adv Gastroenterol"},{"issue":"8","key":"769_CR245","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41584-023-00984-8","volume":"19","author":"G Cozzi","year":"2023","unstructured":"Cozzi G, Scagnellato L, Lorenzin M, Savarino E, Zingone F, Ometto F, et al. Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies. Nat Rev Rheumatol. 2023;19(8):503\u201318.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"769_CR246","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001342","volume":"11","author":"BJ Kim","year":"2024","unstructured":"Kim BJ, Thiemann A, Dietz B, Beck K. Refractory ulcerative colitis with associated synovitis, acne, pustulosis, hyperostosis, osteitis syndrome successfully treated with tofacitinib. ACG Case Rep J. 2024;11(4):e01342.","journal-title":"ACG Case Rep J"},{"issue":"9","key":"769_CR247","volume":"17","author":"AA Almalaq","year":"2025","unstructured":"Almalaq AA, Almasoud A, Almeghaiseeb E, Alamro R, Albishi AM, Alrashidi S, et al. From the gut to the bone: a narrative review of the synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO)-inflammatory bowel disease (IBD) overlap syndrome. Cureus. 2025;17(9):e92230.","journal-title":"Cureus."},{"key":"769_CR248","first-page":"8157969","volume":"2019","author":"VC De Guerra","year":"2019","unstructured":"De Guerra VC, Hashmi H, Kramer B, Balluz R, Son MB, Stein D, et al. A case report of Takayasu\u2019s arteritis and ulcerative colitis in a pediatric patient with chronic recurrent multifocal osteomyelitis successfully treated with infliximab: diagnostic clues in disease associations and immune dysregulation. Case Rep Rheumatol. 2019;2019:8157969.","journal-title":"Case Rep Rheumatol."},{"issue":"1","key":"769_CR249","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3899\/jrheum.160491","volume":"44","author":"G Vettiyil","year":"2017","unstructured":"Vettiyil G, Punnen A, Kumar S. An unusual association of chronic recurrent multifocal osteomyelitis, pyoderma gangrenosum, and Takayasu arteritis. J Rheumatol. 2017;44(1):127\u20138.","journal-title":"J Rheumatol"},{"issue":"1","key":"769_CR250","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000551171","volume":"20","author":"Y Yamane","year":"2026","unstructured":"Yamane Y, Hashimoto K, Yuda A, Sasaki M. Emergence of Takayasu arteritis and chronic recurrent multifocal osteomyelitis during maintenance therapy in remission 13 years after the diagnosis of very early-onset ulcerative colitis: a case report. Case Rep Gastroenterol. 2026;20(1):63\u201371.","journal-title":"Case Rep Gastroenterol"},{"issue":"5","key":"769_CR251","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2008","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR\/PRINTO\/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2008;69(5):798\u2013806.","journal-title":"Ann Rheum Dis"},{"key":"769_CR252","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fped.2018.00265","volume":"6","author":"RAG Russo","year":"2018","unstructured":"Russo RAG, Katsicas MM. Takayasu arteritis. Front Pediatr. 2018;6:265.","journal-title":"Front Pediatr"},{"issue":"3","key":"769_CR253","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030271","volume":"13","author":"L La Barbera","year":"2024","unstructured":"La Barbera L, Rizzo C, Camarda F, Miceli G, Tuttolomondo A, Guggino G. The contribution of innate immunity in large-vessel vasculitis: detangling new pathomechanisms beyond the onset of vascular inflammation. Cells. 2024;13(3):271.","journal-title":"Cells"},{"issue":"1 Suppl.","key":"769_CR254","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1016\/j.jhep.2005.11.028","volume":"44","author":"JM Miro","year":"2006","unstructured":"Miro JM, Laguno M, Moreno A, Rimola A, Hospital Clinic Olt In Hiv Working G. Management of end stage liver disease (ESLD): what is the current role of orthotopic liver transplantation (OLT)? J Hepatol. 2006;44(1 Suppl.):S140\u20135.","journal-title":"J Hepatol"},{"issue":"3","key":"769_CR255","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","volume":"77","author":"Y Nakaoka","year":"2018","unstructured":"Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis. 2018;77(3):348\u201354.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"769_CR256","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/rheumatology\/kez630","volume":"59","author":"Y Nakaoka","year":"2020","unstructured":"Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H, et al. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford). 2020;59(9):2427\u201334.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"769_CR257","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102634","volume":"19","author":"P Mertz","year":"2020","unstructured":"Mertz P, Kleinmann JF, Lambert M, Puechal X, Bonnin A, Boulon C, et al. Infliximab is an effective glucocorticoid-sparing treatment for Takayasu arteritis: results of a multicenter open-label prospective study. Autoimmun Rev. 2020;19(10):102634.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"769_CR258","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.semarthrit.2021.09.010","volume":"51","author":"F Alibaz-Oner","year":"2021","unstructured":"Alibaz-Oner F, Kaymaz-Tahra S, Bayindir O, Yazici A, Ince B, Kalkan K, et al. Biologic treatments in Takayasu\u2019s arteritis: a comparative study of tumor necrosis factor inhibitors and tocilizumab. Semin Arthritis Rheum. 2021;51(6):1224\u20139.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"769_CR259","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103275","volume":"22","author":"DP Misra","year":"2023","unstructured":"Misra DP, Singh K, Rathore U, Patro P, Tomelleri A, Campochiaro C, et al. The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu arteritis: a systematic review and meta-analysis. Autoimmun Rev. 2023;22(3):103275.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"769_CR260","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.semarthrit.2016.07.012","volume":"46","author":"ED Batu","year":"2017","unstructured":"Batu ED, Sonmez HE, Hazirolan T, Ozaltin F, Bilginer Y, Ozen S. Tocilizumab treatment in childhood Takayasu arteritis: case series of four patients and systematic review of the literature. Semin Arthritis Rheum. 2017;46(4):529\u201335.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"769_CR261","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1093\/rheumatology\/keac149","volume":"61","author":"S Sener","year":"2022","unstructured":"Sener S, Basaran O, Kaya Akca U, Atalay E, Kasap Cuceoglu M, Balik Z, et al. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents. Rheumatology (Oxford). 2022;61(12):4885\u201391.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"769_CR262","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/rheumatology\/key322","volume":"58","author":"N de Graeff","year":"2019","unstructured":"de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, et al. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides: the SHARE initiative. Rheumatology (Oxford). 2019;58(4):656\u201371.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"769_CR263","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.ard.2025.05.020","volume":"84","author":"E Sag","year":"2025","unstructured":"Sag E, Oton T, Carmona L, Ozen S. Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR\/PReS recommendations for familial Mediterranean fever. Ann Rheum Dis. 2025;84(11):1909\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"769_CR264","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10067-025-07306-1","volume":"44","author":"B Oksuz Aydin","year":"2025","unstructured":"Oksuz Aydin B, Aydin F, Tas O, Bahceci O, Ozcakar ZB. Associated diseases and their effects on disease course in patients with chronic non-bacterial osteomyelitis: retrospective experience from a single center. Clin Rheumatol. 2025;44(2):855\u201362.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"769_CR265","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/RHU.0000000000002061","volume":"30","author":"N Karacayir","year":"2024","unstructured":"Karacayir N, Tuncez S, Oner N, Celikel E, Baglan E, Gezgin-Yildirim D, et al. Chronic nonbacterial osteomyelitis associated with familial Mediterranean fever in children. J Clin Rheumatol. 2024;30(3):89\u201393.","journal-title":"J Clin Rheumatol"},{"issue":"6","key":"769_CR266","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/ahg.12404","volume":"84","author":"D Ait-Idir","year":"2020","unstructured":"Ait-Idir D, Djerdjouri B. Differential mutational profiles of familial Mediterranean fever in North Africa. Ann Hum Genet. 2020;84(6):423\u201330.","journal-title":"Ann Hum Genet"},{"issue":"5","key":"769_CR267","first-page":"112","volume":"127","author":"PO Avar-Aydin","year":"2020","unstructured":"Avar-Aydin PO, Ozcakar ZB, Cakar N, Fitoz S, Yalcinkaya F. Chronic non-bacterial osteomyelitis: another disease associated with MEFV gene mutations. Clin Exp Rheumatol. 2020;127(5):112\u20137.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"769_CR268","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","volume":"84","author":"S Ozen","year":"2025","unstructured":"Ozen S, Sag E, Oton T, Gul A, Sieiro Santos C, Bayraktar D, et al. EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Ann Rheum Dis. 2025;84(6):899\u2013909.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"769_CR269","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/art.38615","volume":"66","author":"PA Nigrovic","year":"2014","unstructured":"Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol. 2014;66(6):1405\u201313.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"769_CR270","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes JE, Chan TC, Krueger JG. Psoriasis pathogenesis and the development of novel targeted immune therapies. J Allergy Clin Immunol. 2017;140(3):645\u201353.","journal-title":"J Allergy Clin Immunol"},{"issue":"27","key":"769_CR271","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1056\/NEJMra2002697","volume":"383","author":"JT Chang","year":"2020","unstructured":"Chang JT. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652\u201364.","journal-title":"N Engl J Med"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-026-00769-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-026-00769-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:08:47Z","timestamp":1790683727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-026-00769-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":271,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["769"],"URL":"https:\/\/doi.org\/10.1007\/s40272-026-00769-y","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Schnabel, Giulia Inguscio, and E Roberts, have no conflicts of interest to disclose. Christian M. Hedrich receives unrestricted research funding from Merck (MISP programme) to study lupus nephritis.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AS, GI, ER, and CMH wrote the first draft of this manuscript, revised the manuscript, added to the discussion, and agreed to the final version.","order":7,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}}]}}